Serie de vídeos con expertos mundiales que debaten la evaluación y el tratamiento del riesgo aterosclerótico con un enfoque específico en el papel de la inflamación.
Video series with global experts discussing the assessment and management of atherosclerotic risk with a specific focus on the role of inflammation.
Thought Leadership Piece By IAS President Dirk Blom, MBChB, MMed, FCP (SA), PhD
Croatian translation of the “Factors Affecting Patients’ Use of Statins” infographic.
Watch the newest episode of IAS’ Leading Insights series to learn from Prof. Jessica M. Peña and Prof. Alexander van Rosendael as they discuss the latest study findings using CONFIRM2, the largest registry of quantification of atherosclerosis. IAS received an unrestricted grant from Cleerly to develop this resource. About Leading InsightsLeading Insights is a video series in which IAS’ global experts discuss recent research findings about breakthrough diagnostic tools, therapies and devices relevant to the diagnosis and management of […]
Artificial Intelligence Quantitative Computed Tomography (AI-QCT) uses AI technology to analyze the amount, composition, and stenosis of coronary artery plaque. IAS received an unrestricted grant from Cleerly to develop this resource.
Recordings of the live lectures from the Inflammation Academy, held in Madrid on August 28, 2025
This first graphic explains the formation of triglycerides and how their concentration in blood serves as a biomarker for TGRL, which promote the formation of atheroma.
This second graphic shows the associated risk for different concentrations of triglycerides in the blood.
This third graphic demonstrates some lifestyle behaviors that can reduce the risk of hypertriglyceridemia.
This fourth graphic outlines the available therapeutic options for severe hypertriglyceridemia as well as novel therapies in development.
This fifth graphic delineates how icosapent ethyl can be used for CV risk reduction as demonstrated by the REDUCE-IT trial.
The IAS e-Newsletter is a digest of the latest from the IAS and its Constituent Member Societies.
Going beyond statins, this resource provides the latest information about primary prevention for clinicians.
